These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 36382839)

  • 21. Improved Survival After Adjuvant Therapy in Locally Advanced Rectal Cancer Patients With Pathologic Complete Response.
    Lai SH; Vogel JD; Vemuru S; Messersmith W; Lieu C; McCarter MD; Birnbaum E; Chapman BC
    Dis Colon Rectum; 2023 Jul; 66(7):983-993. PubMed ID: 36602514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors and Outcomes of Upstaging in Rectal Cancer Patients Who Did Not Receive Preoperative Therapy.
    Antunez AG; Kanters AE; Regenbogen SE
    Dis Colon Rectum; 2023 Jan; 66(1):59-66. PubMed ID: 35905174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guideline-Recommended Chemoradiation for Patients With Rectal Cancer at Large Hospitals: A Trend in the Right Direction.
    Del Vecchio NJ; Schlichting JA; Chioreso C; Kahl AR; Hrabe JE; Lynch CF; West MM; Charlton ME
    Dis Colon Rectum; 2019 Oct; 62(10):1186-1194. PubMed ID: 31490827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy.
    Chapman WC; Kim H; Bauer P; Makhdoom BA; Trikalinos NA; Pedersen KS; Glasgow SC; Mutch MG; Silviera ML; Roy A; Parikh PJ; Hunt SR
    Dis Colon Rectum; 2022 Feb; 65(2):198-206. PubMed ID: 34990423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and Safety of a Nonanimal Stabilized Hyaluronic Acid/Dextranomer in Improving Fecal Incontinence: A Prospective, Single-Arm, Multicenter, Clinical Study With 36-Month Follow-up.
    Quiroz LH; Galliano DE; da Silva G; Carmichael JC; Pan LC; Bromley ER; Hinahara JG; Goss TF
    Dis Colon Rectum; 2023 Feb; 66(2):278-287. PubMed ID: 35001051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Significance of Preoperative and Postoperative Serum CEA and Carbohydrate Antigen 19-9 Levels in Patients Undergoing Curative Resection of Locally Recurrent Rectal Cancer.
    Paku M; Uemura M; Kitakaze M; Miyoshi N; Takahashi H; Mizushima T; Doki Y; Eguchi H
    Dis Colon Rectum; 2023 Mar; 66(3):392-400. PubMed ID: 36649161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anastomotic Height Is a Valuable Indicator of Long-term Bowel Function Following Surgery for Rectal Cancer.
    Verkuijl SJ; Hoff C; Furnée EJB; Kelder W; Hess DA; Wit F; Zijlstra RJ; Trzpis M; Broens PMA
    Dis Colon Rectum; 2023 Feb; 66(2):221-232. PubMed ID: 35714360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome.
    Rizzo G; Pafundi DP; Sionne F; Pietricola G; D'Agostino L; Gambacorta MA; Valentini V; Coco C
    Dis Colon Rectum; 2022 Nov; 65(11):1306-1315. PubMed ID: 35067503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient Satisfaction With Long-term Sacral Neuromodulation for Fecal Incontinence: Experience From a Single Tertiary Center.
    Martin SA; O'Connor AD; Selvakumar D; Baraza W; Faulkner G; Mullins D; Kiff ES; Telford KJ; Sharma A
    Dis Colon Rectum; 2024 Sep; 67(9):1177-1184. PubMed ID: 38848132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Addition of Preoperative Radiation Is Insufficient for Lateral Pelvic Control in a Subgroup of Patients With Low Locally Advanced Rectal Cancer: A Post Hoc Study of a Randomized Controlled Trial.
    Xie Y; Lin J; Wang X; Wang P; Zhuang Z; Zou Q; Cai D; Huang Z; Bai L; Tang G; Huang M; Wang J; Yu H; Luo Y
    Dis Colon Rectum; 2021 Nov; 64(11):1321-1330. PubMed ID: 33990500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of Patients With Local Regrowth After Nonoperative Management of Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Cotti GC; Pandini RV; Braghiroli OFM; Nahas CSR; Bustamante-Lopez LA; Marques CFS; Imperiale AR; Ribeiro U; Salvajoli B; Hoff PM; Nahas SC
    Dis Colon Rectum; 2022 Mar; 65(3):333-339. PubMed ID: 34775415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perirenal Fat Surface Area and Oncologic Outcome in Elective Colon Cancer Surgery.
    Eckberg SE; Dahlberg MJA; der Hagopian OS; Farahnak P; Sandblom GK; Nordenvall CAM; Everhov ÅH
    Dis Colon Rectum; 2021 Feb; 64(2):171-180. PubMed ID: 33315716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient Survival With ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer.
    Elshami M; Goldstone RN; Blaszkowsky LS; Cusack JC; Hong TS; Wo JY; Qadan M
    Dis Colon Rectum; 2022 Oct; 65(10):1224-1231. PubMed ID: 35714358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Association Between Modifiable Lifestyle Factors and Postoperative Complications of Elective Surgery in Patients With Colorectal Cancer.
    Loogman L; de Nes LCF; Heil TC; Kok DEG; Winkels RM; Kampman E; de Wilt JHW; van Duijnhoven FJB; ;
    Dis Colon Rectum; 2021 Nov; 64(11):1342-1353. PubMed ID: 34082436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges and Opportunities in the Elective Management of Diverticulitis: Perspectives From a National Sample of Colorectal Surgeons.
    Williamson AJH; Cain BT; Hoggan TJ; Larsen MW; Kimball ER; Bloomquist K; Galyean PO; Zickmund S; Cohan JN
    Dis Colon Rectum; 2024 Feb; 67(2):264-272. PubMed ID: 37787524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anastomosis-Related Complications After Stapled Anastomosis With Reinforced Sutures in Transanal Total Mesorectal Excision for Low Rectal Cancer: A Retrospective Single-Center Study.
    Enomoto H; Ito M; Sasaki T; Nishizawa Y; Tsukada Y; Ikeda K; Hasegawa H
    Dis Colon Rectum; 2022 Feb; 65(2):246-253. PubMed ID: 34657080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.
    Zhang J; Li J; Huang M; Xie X; Cai Y; Hu H; Ling J; Wu Z; Deng Y
    Dis Colon Rectum; 2023 Jul; 66(7):934-945. PubMed ID: 35834598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transanal Total Mesorectal Excision: Short-term Outcomes of 1283 Cases from a Nationwide Registry in China.
    Yao H; An Y; Zhang H; Ren M; Chen CC; Xu Q; Wang Q; Zhang Z;
    Dis Colon Rectum; 2021 Feb; 64(2):190-199. PubMed ID: 33395134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total Neoadjuvant Therapy Significantly Increases Complete Clinical Response.
    Rettig RL; Beard BW; Ryoo JJ; Kulkarni S; Gulati M; Tam M; Attaluri V
    Dis Colon Rectum; 2023 Mar; 66(3):374-382. PubMed ID: 35239525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.